Member Info for JustHereForHemo

We know from the trades printed today a shorter got burnt trying to short hemogenyx last few days, looks like it was scoot. Very angry and understandably so. Positive posting by many on this board counteracted the lies and miss information and as a result shorters got burnt. Sorry scoot, move on, try Rest or something to short.

Micky, I don't think that will happen on a deal. Problem with this finding rns was a lot of people did not understand it and all the other juicy stuff was hidden further down. Even with the shorters dumping tonne of shares all they did was kill some of the rise and ended up losing money and closing at a loss. Clear deal rns they will not dare

Quiet but rewarding, looks like we had a few shorts after that RNS, but they have closed today, one making a significant loss. SP pretty flat, PEEL trying to claw back the shorted shares and not getting many sells. For sure this did not go how the shorters or MM's had hoped, too many sticky shares in investors hands. A very good confidence building day. When shorters close and take a loss instead of doubling down you can be sure your on to a winner.

@bhundinare no a bed an isa shows as a sell then a buy, I have been told this is a short position that was opened up at the recorded time, being recorded now as the position is being closed. They never actually held any shares to sell so it just cancels out the original order.

It looks like some people shorted hemo after than RNS came out, not fully reading it, thats why the SP fell back again. They probably read CLN and snap reaction thought they could sell it as bad news. Problem is they didnt read the rest of the RNS and did not know the background to Hemo and what is going on with Eli Lilly. Anyway one of the shorters made a small profit, the other lost money.
It makes alot more sense now atleast, the drop didnt make sense, all the LTHers I have been talking to seen it as positive and none of them had sold, all added or held, I added. Poster on here was called purple was loosing his head trying to convince people to sell then moved to advfn when he got banned here and losing his head there ever since trying to convince people to sell. So I am guessing he lost on his short, ah well ;-)

Assuming Pingu and others are right and the loan is a power play how does that change the dynamics? My initial thought was Hemo would get the cash immediately, file for INDs and push ahead straight away at the expense of a significant level of dilution. But having looked into the prospectus required to release this loan it seems like it may take a while to release the money, potentially into next year. If that is the case why not wait anyway and do a placing? Because of safe guards also the first tranche cannot even be drawn down unless SP improves. However on paper Hemo have a big financier standing behind them backing them saying we will fund 60 million. Looks very much like a power play with a safety net of actual money IF required.

I am not convinced Vlad will ever draw down any of this loan, and if he does, not much more than the first tranche.

People have posted figures on here before about licencing deals and some of the most important factors are How far through trials are they, how much has the small fish already self financed and size of the small fish company. Hemo were incredibly weak in negotiations, no clinical trials, funded by Eli Lilly and Mcap of ~40Mil. Hard for Eli to justify a generous licence agreement and even harder for Hemogenyx to argue, IF they had refused the offer by Eli, they then had to licence off Eli any joint project developments, which previously they were in no position to do.

Eli labs are back open, RNS says "and have nearly completed the manufacturability assessment and follow-up tests on the antibody." Suddenly Vlad comes out with a 60M loan offer NOW, revealing details about CBR Platform etc.

So assuming this is a power play, assume it works and Eli offer a bigger settlement, enough in cash up front that Vlad does not need the Mint loan, that means no dilution atall now and SP goes through the roof. Vlad will still have the loan available but if the MCap was on par with similar small pharmas and somewhere closer to 3-500M MCap, he would only be giving up like 2-4% of the equity, something I dont think anyone on here would mind?

Anyway, right or wrong we should find out soon enough, if we see a prospectus in the next few weeks probably safe to assume loan monies will be shortly behind followed by IND applications etc, if we have radio silence for the next few weeks might mean vlad is in negotiations and the next RNS is the elusive CDX licencing agreement.
Whatever the scenario I dont see a down side from here, nor do I see news being very far away. Either Eli licence, or loan followed by start of Clinical process with CAR-T, either way its going to explode!

If you want in the password is "Pumpkin is a crazy cat lady", please dont share this with anyone.

https://*********************/companies/uk/biotechnology/hemogenyx-pharmaceuticals-plc/research/sp-angel/sp-angel-healthcare-conditions-19-11-2020

Take it nothing new but curious

Most intriguing part of that RNS was the talk about CBR, and this line is very exciting:
" the Directors are not aware of any direct competitor for this product candidate at this time."
Novel new treatment for Covid AND unspecified cancer? I am thinking multiple myeloma which is related to areas of research the company is involved in (bone marrow), has no known cure that I can find and high mortality rate. Would be fantastic if this is the case but we have to wait and see.

Anyway I am certain they will be looking to patent the platform and their 2 early treatments as soon as possible, they have not released much information but surely now race is on to get their IP protected.

Think your maths is off there Doc, SP needs to rise when you consider discount. Even if it was just about high enough to allow the release cant picture Vlad being overly happy giving away so many shares at this early stage of the game, its his shares on the line too. Have to imagine he will delay it until the SP improves, something he can easily achieve with RNS detailing this new platform, or patent for the covid cure, or in Vivo results for SAFE-HEMO-CAR-T etc.

Good to see level heads again, every now and then you see a flurry like Cheapskate on here and Purple on the other site and its like "What on earth am I reading!?!?"

Purple on the other site is just pure bser and I believe shorter no time for him.
Cheapskate, I believe your genuine and your first reading is as you say, and you did rough maths, panicked and sold and I hope you take the time to reevaluate and come back into the fold. I over reacted when the CDX delay was announced and sold most of my shares, then regretted it when I had time to reflect. Bottom line is yesterdays RNS was a stonker of an RNS, like better than expected and points to a significant SP rise in short order. You have genuine concerns about dilution, well thats fair, but seek an independent opinion before you quit on us.

Its the opinion of myself and those I have discussed this with that the loan cant be taken until the SP rises, and then its in Mint's best interests to hold and for the SP to continue to rise.

Exactly, people complaining we may have to give away 30% of the shares to secure 60M.. Well to do that the MCap has to be 180M which is 4-5 times higher than it is today which would equate to what 40s?
You can keep all your shares and your 9-10p sp or you can have an SP 400%+ higher and give Mint 30% of the shares as payment...
There will always be people look for the negatives, but this is a very good deal for all of us.

Mint only make money if the SP continues to grow between tranches, 10% is not what they are after
Mint can only hold 30% of the equity at the end, the first tranche has not yet been drawn down but if it was it would equate to > 30% this is not possible, even if it was exactly 30% this would block all future tranches.
MCap of 55Mil enables first tranche but blocks everything else. Even an SP of 15 gives an MCap of 75m which is possible if SP shoots up but tight. Vlad clearly expected/expects SP to climb significantly from here to enable this funding. So while future funding MIGHT dilute the shares a little it has to be a great deal higher than today before they can even consider it.

The TL;DR condensed version of my post is:
Cheapskater, there are guards built in. The loan being converted to cash is predicated on the SP rising significantly. Your worst case scenario of 40% of shares is not possible as per terms of the deal. Vlad wants this to happen, he wants the cash to pay for IND. What you are going to see now is a big effort to promote the company and raise the SP. The HIGHER the SP the more and more attractive this loan becomes. Vlad cannot now affort to ignore PR and let the SP stagnate, success depends on the SP rising, and when it does and the first tranche is issued, that enables IND + clinical trials which = more positive news.

I am more than happy to be shown I am wrong on this but your fears are unwarranted.

No shares issued yet, we need prospectus - THEN the SP has to be high enough that including the discount the new shares issued remain below 29.9% of total shares.

Panic and fear monger all you want but SP HAS to go up before shares are even issued, and then Mint lose money if the SP falls, 10% discount is TINY. I believe we would need an MCap of atleast 55M before they can be convered? Am I correct?

Cheapskater I think you would have a good point IF hemogenyx was fairly priced among its peers with a reasonable SP to begin, THATS the big picture here. All your figures and assumptions are based on a SP somewhere around where we are today. But thats just not possible, for instance the first tranche of £12m. At todays price that is more than 30% of the MCap, when you add in discount its alot more than 30%. If you read the RNS that prevents the CLN from being convered, see below. Now I am not saying that 12m is not alot of new shares, ofcourse it is but think logically, how on earth would Mint manage to make a profit out of 10% discount with that many shares shorting before listing? Think about it, fine for a Placing an individual PI can short 500k or even 1m shares and get away with it and pocket a few quid. Something like this Mint will want ALOT more than 10% on their investment. Mint have been shown alot more than us and they are here for the big money, they will make a fortune out of Hemo, but not by tanking the SP.

Your opinion is your own and you have made up your mind based on what you believe, fair enough, there is a logic to it. But its so tainted and scarred that I fear your walking away from a gift. Take a moment now and consider if the SP was say 20p+ and our MCap was double. Each dilution was a fraction of what you predicted because of the higher MCap.
Then look at the RNS, ignore the loan aspect and consider what RNS's are now expected:
RNS on patient new Platform
RNS on patient for Covid19 treatment
RNS on patient for undisclosed cancer treatment
RNS for in Vivo/ In vitro and then IND for Covid treatment
RNS for in Vivo for SAFE-HEMO-CAR-T and then adding to Penn agreement
RNS for IND application for SAFE/-HEMO-CAR-T with Penn
RNS for CDX licencing agreement with Eli
RNS for CDX IND application independent targeting ALL
RNS for Lupus update
RNS for HuPHEC now funding is available for Cell bank.

Your opinion is valid IF and ONLY IF the MCap is fair and likely to remain around the same, If you consider the above, do you feel 41M is a fair MCap?

From the RNS:
A holder will not be permitted to submit a conversion notice in respect of the Convertible Loan Notes if the total Ordinary Shares held by the holder following the execution of such conversion notice would exceed 29.9 per cent. of the Company's total Ordinary Shares.

No, sorry to burst your bubble but a swing of 5% is nothing to do with a few people setting sell limits, and for the record I think your mad setting it at 14/15p, we hit that on rumours and petrol fumes before.
SP is rising because it had to rise. Yesterday Hemogenyx secured 60m in funding and in black and white Vlad has stated he is going to use this cash to apply for IND Applications and begin phase 1/2a trials in a range of pipeline projects.
Most of the readers of this board probably have not read the RNS but I guarantee it will have turned heads.
Big orders were placed yesterday and MMs have been filling for the past 2 days, going up does not induce selling, dropping the price does because people come on forums like this and panic and say they are selling and leaving because the SP has dropped.... Like seriously when will people learn?
I placed an order for 325k shares yesterday, when I see that posted I will know atleast one of the MMs is done loading up.

What cheapskate said might hold some truth if we were talking about a 2-300m MCap company getting a 60m loan so dont dismiss out of hand. Difference here is Hemo has been so depressed for so long any negative impact of dilution is just many times outweighed by the potential upside. Becoming a clinical pharma requires cash, but reaching that step makes hemo worth 10 times what it's mCap is today.

Anyway some alternative opinions people have based on personal experience and worth considering, but I doubt the circumstances are anything like hemogenyx.

Dzygit, having been watching this share for a long time I would have put money on the SP dropping BELOW 9p this morning, MMs still paying 9p but they had to take it down to collect shares and trigger stop losses. Best to ignore intra day movements. Market Makers are there to provide liquidity and the only way they can do that is by shaking loose the shares from the weaker PIs. When they dont print buys from the day before you can be sure they are short :-) My buy still not printed

David, 100% the RNS is massive, people are latching onto the fact there will be some dilution to the share pool in 3 years.... Whoopie...
Someone invents a warp drive and decides to keep it to himself to maintain 100% of his profits but never sells a single unit due to lack of funds
Someone else invents a warp drive, takes out 60M in convertable loans in exchange for 10-30% of his business and starts making billions but has to give away 30% of those profits...
Which would you rather Hemogenyx be?

I read the RNS and I think, CBR - WOW potentially massive, Covid cure needs funds for IND Application?? They are already well advanced and when this happens it will be huge. Funds for CAR-T IND? Thats what I have been waiting for. Warning shot across the bow of Eli? Sounds to me Vlad is not happy with the deal on the table and now he has the muscle behind him to negotiate a better deal or take this solo and not share the profits. And so on...
OTHERS like Pumpkin see an RNS and its: Voom, lets scan this RNS and see if there are any key words we can try and spin as a negative and latch on that. They DONT GIVE A TOSS about the company, the work, the actual contents of the RNS, its all foreign language to those idiots, they look for anything they can spin as negative, then they distort, expand and bs to try and make every RNS look negative. Its sad, its pathetic and speaks more about the person than anything else.

The Finder? Do you mean Mint the funder?
Probably in 3 years when they are able to considering its part of the RNS that you clearly didn't read but decided to come back and spew your uninformed unwelcome useless opinion anyway :-)